{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:05:35Z","timestamp":1790726735444,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"University of Malaya Grand Challenge","award":["GC002-14HTM"],"award-info":[{"award-number":["GC002-14HTM"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s10620-017-4871-9","type":"journal-article","created":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T01:43:38Z","timestamp":1512092618000},"page":"1250-1260","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Efficacy of Rebamipide in Organic and Functional Dyspepsia: A Systematic Review and Meta-Analysis"],"prefix":"10.1007","volume":"63","author":[{"given":"Mohamed Hasif","family":"Jaafar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sher Zaman","family":"Safi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maw-Pin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Rampal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5824-0590","authenticated-orcid":false,"given":"Sanjiv","family":"Mahadeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,1]]},"reference":[{"key":"4871_CR1","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.3748\/wjg.v12.i17.2661","volume":"12","author":"S Mahadeva","year":"2006","unstructured":"Mahadeva S, Goh KL. Epidemiology of functional dyspepsia: a global perspective. World J Gastroenterol. 2006;12:2661\u20132666.","journal-title":"World J Gastroenterol"},{"key":"4871_CR2","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/gutjnl-2014-307843","volume":"64","author":"AC Ford","year":"2015","unstructured":"Ford AC, Marwaha A, Sood R, et al. Global prevalence of, and risk factors for, uninvestigated dyspepsia: a meta-analysis. Gut. 2015;64:1049\u20131057.","journal-title":"Gut"},{"key":"4871_CR3","first-page":"830-7","volume":"8","author":"AC Ford","year":"2010","unstructured":"Ford AC, Marwaha A, Lim A, et al. What is the prevalence of clinically significant endoscopic findings in subjects with dyspepsia? Systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2010;8:830-7\u2013837e1-2.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4871_CR4","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1007\/s10620-012-2256-7","volume":"57","author":"S Mahadeva","year":"2012","unstructured":"Mahadeva S, Goh KL. Clinically significant endoscopic findings in a multi-ethnic population with uninvestigated dyspepsia. Dig Dis Sci. 2012;57:3205\u20133212.","journal-title":"Dig Dis Sci"},{"key":"4871_CR5","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1111\/j.1365-2036.2005.02455.x","volume":"21","author":"S Mahadeva","year":"2005","unstructured":"Mahadeva S, Raman MC, Ford AC, et al. Gastro-oesophageal reflux is more prevalent in Western dyspeptics: a prospective comparison of British and South-East Asian patients with dyspepsia. Aliment Pharmacol Ther. 2005;21:1483\u20131490.","journal-title":"Aliment Pharmacol Ther"},{"key":"4871_CR6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/nmo.12657","volume":"28","author":"S Mahadeva","year":"2016","unstructured":"Mahadeva S, Ford AC. Clinical and epidemiological differences in functional dyspepsia between the East and the West. Neurogastroenterol Motil. 2016;28:167\u2013174.","journal-title":"Neurogastroenterol Motil"},{"key":"4871_CR7","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s00535-008-2172-y","volume":"43","author":"Y Matsumoto","year":"2008","unstructured":"Matsumoto Y, Ito M, Kamino D, et al. Relation between histologic gastritis and gastric motility in Japanese patients with functional dyspepsia: evaluation by transabdominal ultrasonography. J Gastroenterol. 2008;43:332\u2013337.","journal-title":"J Gastroenterol"},{"key":"4871_CR8","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3109\/00365529409094858","volume":"29","author":"E Trespi","year":"1994","unstructured":"Trespi E, Broglia F, Villani L, et al. Distinct profiles of gastritis in dyspepsia subgroups. Their different clinical responses to gastritis healing after Helicobacter pylori eradication. Scand J Gastroenterol. 1994;29:884\u2013888.","journal-title":"Scand J Gastroenterol"},{"key":"4871_CR9","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/jcp.48.4.325","volume":"48","author":"AM Zaitoun","year":"1995","unstructured":"Zaitoun AM. The prevalence of lymphoid follicles in Helicobacter pylori associated gastritis in patients with ulcers and non-ulcer dyspepsia. J Clin Pathol. 1995;48:325\u2013329.","journal-title":"J Clin Pathol"},{"key":"4871_CR10","first-page":"594","volume":"48","author":"J Kyzekove","year":"2001","unstructured":"Kyzekove J, Arlt J, Arltova M. Is there any relationship between functional dyspepsia and chronic gastritis associated with Helicobacter pylori infection? Hepatogastroenterology. 2001;48:594\u2013602.","journal-title":"Hepatogastroenterology"},{"key":"4871_CR11","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrgastro.2013.9","volume":"10","author":"H Suzuki","year":"2013","unstructured":"Suzuki H, Moayyedi P. Helicobacter pylori infection in functional dyspepsia. Nat Rev Gastroenterol Hepatol. 2013;10:168\u2013174.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4871_CR12","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1136\/gut.2005.080358","volume":"55","author":"GM Naylor","year":"2006","unstructured":"Naylor GM, Gotoda T, Dixon M, et al. Why does Japan have a high incidence of gastric cancer? Comparison of gastritis between UK and Japanese patients. Gut. 2006;55:1545\u20131552.","journal-title":"Gut"},{"key":"4871_CR13","first-page":"5S","volume":"43","author":"T Arakawa","year":"1998","unstructured":"Arakawa T, Kobayashi K, Yoshikawa T, et al. Rebamipide: overview of its mechanisms of action and efficacy in mucosal protection and ulcer healing. Dig Dis Sci. 1998;43:5S\u201313S.","journal-title":"Dig Dis Sci"},{"key":"4871_CR14","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0022-3565(24)38925-6","volume":"295","author":"WH Sun","year":"2000","unstructured":"Sun WH, Tsuji S, Tsujii M, et al. Induction of cyclooxygenase-2 in rat gastric mucosa by rebamipide, a mucoprotective agent. J Pharmacol Exp Ther. 2000;295:447\u2013452.","journal-title":"J Pharmacol Exp Ther"},{"key":"4871_CR15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000201312","volume":"57","author":"M Tabata","year":"1996","unstructured":"Tabata M, Tomomasa T, Itoh K, et al. Effect of 10% ethanol and sofalcone on prostaglandin E2 content, mucus gel thickness, and experimental ulcers in the stomach of developing rats. Digestion. 1996;57:47\u201353.","journal-title":"Digestion"},{"key":"4871_CR16","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1046\/j.1440-1746.2001.02606.x","volume":"16","author":"K Adachi","year":"2001","unstructured":"Adachi K, Suetsugu H, Moriyama N, et al. Influence of Helicobacter pylori infection and cetraxate on gastric mucosal blood flow during healing of endoscopic mucosal resection-induced ulcers. J Gastroenterol Hepatol. 2001;16:1211\u20131216.","journal-title":"J Gastroenterol Hepatol"},{"key":"4871_CR17","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1007\/s10620-005-2800-9","volume":"50","author":"T Arakawa","year":"2005","unstructured":"Arakawa T, Higuchi K, Fujiwara Y, et al. 15th anniversary of rebamipide: looking ahead to the new mechanisms and new applications. Dig Dis Sci. 2005;50:S3\u2013S11.","journal-title":"Dig Dis Sci"},{"key":"4871_CR18","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1046\/j.1365-2036.2001.01074.x","volume":"15","author":"NJ Talley","year":"2001","unstructured":"Talley NJ, Riff DS, Schwartz H, et al. Double-blind placebo-controlled multicentre studies of rebamipide, a gastroprotective drug, in the treatment of functional dyspepsia with or without Helicobacter pylori infection. Aliment Pharmacol Ther. 2001;15:1603\u20131611.","journal-title":"Aliment Pharmacol Ther"},{"key":"4871_CR19","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1111\/j.1440-1746.2006.04446.x","volume":"21","author":"H Miwa","year":"2006","unstructured":"Miwa H, Osada T, Nagahara A, et al. Effect of a gastro-protective agent, rebamipide, on symptom improvement in patients with functional dyspepsia: a double-blind placebo-controlled study in Japan. J Gastroenterol Hepatol. 2006;21:1826\u20131831.","journal-title":"J Gastroenterol Hepatol"},{"key":"4871_CR20","first-page":"156","volume":"85","author":"AH Syam","year":"2012","unstructured":"Syam AH, Simadibrata M, Rani A, et al. Rebamipide effect on chronic gastritis in dyspeptic patient: symptoms, endoscopic and histological evaluation. Digestion. 2012;85:156.","journal-title":"Digestion"},{"key":"4871_CR21","doi-asserted-by":"crossref","first-page":"240","DOI":"10.4093\/dmj.2016.40.3.240","volume":"40","author":"S Park","year":"2016","unstructured":"Park S, Park SY, Kim YJ, et al. Effects of rebamipide on gastrointestinal symptoms in patients with type 2 diabetes mellitus. Diabetes Metab J. 2016;40:240\u2013247.","journal-title":"Diabetes Metab J"},{"key":"4871_CR22","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.","journal-title":"PLoS Med"},{"key":"4871_CR23","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/bmj.302.6779.749","volume":"302","author":"R Johnsen","year":"1991","unstructured":"Johnsen R, Bernersen B, Straume B, et al. Prevalences of endoscopic and histological findings in subjects with and without dyspepsia. BMJ. 1991;302:749\u2013752.","journal-title":"BMJ"},{"key":"4871_CR24","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0016-5107(92)70432-5","volume":"38","author":"TT Schubert","year":"1992","unstructured":"Schubert TT, Schubert AB, Ma CK. Symptoms, gastritis, and Helicobacter pylori in patients referred for endoscopy. Gastrointest Endosc. 1992;38:357\u2013360.","journal-title":"Gastrointest Endosc"},{"key":"4871_CR25","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/j.1572-0241.1998.332_a.x","volume":"93","author":"F Parente","year":"1998","unstructured":"Parente F, Imbesi V, Maconi G, et al. Influence of bacterial CagA status on gastritis, gastric function indices, and pattern of symptoms in H. pylori-positive dyspeptic patients. Am J Gastroenterol. 1998;93:1073\u20131079.","journal-title":"Am J Gastroenterol"},{"key":"4871_CR26","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.","journal-title":"BMJ"},{"key":"4871_CR27","first-page":"175","volume":"36","author":"JS Rew","year":"2000","unstructured":"Rew JS, Joo YE, Kim HS, et al. Efficacy of rebamipide maintenance therapy after eradication of Helicobacter pylori infection in patients with chronic gastritis or gastric ulcer. Kor J Gastroenterol. 2000;36:175\u2013184.","journal-title":"Kor J Gastroenterol"},{"key":"4871_CR28","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1007\/s10620-012-2087-6","volume":"57","author":"K Adachi","year":"2012","unstructured":"Adachi K, Furuta K, Miwa H, et al. A study on the efficacy of rebamipide for patients with proton pump inhibitor-refractory non-erosive reflux disease. Dig Dis Sci. 2012;57:1609\u20131617.","journal-title":"Dig Dis Sci"},{"key":"4871_CR29","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.3109\/s10165-012-0819-2","volume":"23","author":"M Hasegawa","year":"2013","unstructured":"Hasegawa M, Horiki N, Tanaka K, et al. The efficacy of rebamipide add-on therapy in arthritic patients with COX-2 selective inhibitor-related gastrointestinal events: a prospective, randomized, open-label blinded-endpoint pilot study by the GLORIA study group. Mod Rheumatol. 2013;23:1172\u20131178.","journal-title":"Mod Rheumatol"},{"key":"4871_CR30","doi-asserted-by":"crossref","first-page":"155","DOI":"10.5551\/jat.E615","volume":"16","author":"T Kawai","year":"2009","unstructured":"Kawai T, Yamagishi T, Goto S. Circadian variations of gastrointestinal mucosal damage detected with transnasal endoscopy in apparently healthy subjects treated with low-dose aspirin (ASA) for a short period. J Atheroscler Thromb. 2009;16:155\u2013163.","journal-title":"J Atheroscler Thromb"},{"key":"4871_CR31","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.3748\/wjg.v17.i46.5117","volume":"17","author":"K Mizukami","year":"2011","unstructured":"Mizukami K, Murakami K, Abe T, et al. Aspirin-induced small bowel injuries and the preventive effect of rebamipide. World J Gastroenterol. 2011;17:5117\u20135122.","journal-title":"World J Gastroenterol"},{"key":"4871_CR32","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3164\/jcbn.2008041","volume":"43","author":"Y Naito","year":"2008","unstructured":"Naito Y, Iinuma S, Yagi N, et al. Prevention of indomethacin-induced gastric mucosal injury in helicobacter pylori-negative healthy volunteers: a comparison study rebamipide vs famotidine. J Clin Biochem Nutr. 2008;43:34\u201340.","journal-title":"J Clin Biochem Nutr"},{"key":"4871_CR33","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1007\/s10620-014-3108-4","volume":"59","author":"K Tozawa","year":"2014","unstructured":"Tozawa K, Oshima T, Okugawa T, et al. A randomized, double-blind, placebo-controlled study of rebamipide for gastric mucosal injury taking aspirin with or without clopidogrel. Dig Dis Sci. 2014;59:1885\u20131890.","journal-title":"Dig Dis Sci"},{"key":"4871_CR34","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1007\/s10620-006-9367-y","volume":"52","author":"HK Kim","year":"2007","unstructured":"Kim HK, Kim JI, Kim JK, et al. Preventive effects of rebamipide on NSAID-induced gastric mucosal injury and reduction of gastric mucosal blood flow in healthy volunteers. Dig Dis Sci. 2007;52:1776\u20131782.","journal-title":"Dig Dis Sci"},{"key":"4871_CR35","doi-asserted-by":"crossref","first-page":"371","DOI":"10.5009\/gnl.2014.8.4.371","volume":"8","author":"JH Kim","year":"2014","unstructured":"Kim JH, Park SH, Cho CS, et al. Preventive efficacy and safety of rebamipide in nonsteroidal anti-inflammatory drug-induced mucosal toxicity. Gut Liver. 2014;8:371\u2013379.","journal-title":"Gut Liver"},{"key":"4871_CR36","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1007\/s10620-007-0180-z","volume":"53","author":"Y Du","year":"2008","unstructured":"Du Y, Li Z, Zhan X, et al. Anti-inflammatory effects of rebamipide according to Helicobacter pylori status in patients with chronic erosive gastritis: a randomized sucralfate-controlled multicenter trial in China-STARS study. Dig Dis Sci. 2008;53:2886\u20132895.","journal-title":"Dig Dis Sci"},{"key":"4871_CR37","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s40261-015-0329-z","volume":"35","author":"X Han","year":"2015","unstructured":"Han X, Jiang K, Wang B, et al. Effect of rebamipide on the premalignant progression of chronic gastritis: a randomized controlled study. Clin Drug Investig. 2015;35:665\u2013673.","journal-title":"Clin Drug Investig"},{"key":"4871_CR38","first-page":"82","volume":"10","author":"T Seearamroongruang","year":"2009","unstructured":"Seearamroongruang T, Chunlertrith K, Mairiang P, et al. Effect of rebamipide combined with omeprazole on symptom improvement in non-helicobacter pylori gastritis. Thai J Gastroenterol. 2009;10:82\u201390.","journal-title":"Thai J Gastroenterol"},{"key":"4871_CR39","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12876-016-0472-x","volume":"16","author":"T Gagliano-Juca","year":"2016","unstructured":"Gagliano-Juca T, Moreno RA, Zaminelli T, et al. Rebamipide does not protect against naproxen-induced gastric damage: a randomized double-blind controlled trial. BMC Gastroenterol. 2016;16:58.","journal-title":"BMC Gastroenterol"},{"key":"4871_CR40","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3164\/jcbn.40.148","volume":"40","author":"SH Park","year":"2007","unstructured":"Park SH, Cho CS, Lee OY, et al. Comparison of prevention of NSAID-induced gastrointestinal complications by rebamipide and misoprostol: a randomized, multicenter, controlled trial-STORM STUDY. J Clin Biochem Nutr. 2007;40:148\u2013155.","journal-title":"J Clin Biochem Nutr"},{"key":"4871_CR41","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000329353","volume":"84","author":"KH Song","year":"2011","unstructured":"Song KH, Lee YC, Fan DM, et al. Healing effects of rebamipide and omeprazole in Helicobacter pylori-positive gastric ulcer patients after eradication therapy: a randomized double-blind, multinational, multi-institutional comparative study. Digestion. 2011;84:221\u2013229.","journal-title":"Digestion"},{"key":"4871_CR42","doi-asserted-by":"crossref","first-page":"910","DOI":"10.5009\/gnl15537","volume":"10","author":"SJ Hong","year":"2016","unstructured":"Hong SJ, Park SH, Moon JS, et al. The benefits of combination therapy with esomeprazole and rebamipide in symptom improvement in reflux esophagitis: an international multicenter study. Gut Liver. 2016;10:910\u2013916.","journal-title":"Gut Liver"},{"key":"4871_CR43","doi-asserted-by":"crossref","first-page":"865146","DOI":"10.1155\/2015\/865146","volume":"2015","author":"T Kamada","year":"2015","unstructured":"Kamada T, Sato M, Tokutomi T, et al. Rebamipide improves chronic inflammation in the lesser curvature of the corpus after Helicobacter pylori eradication: a multicenter study. Biomed Res Int. 2015;2015:865146.","journal-title":"Biomed Res Int"},{"key":"4871_CR44","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1523-5378.2007.00520.x","volume":"12","author":"X Jin","year":"2007","unstructured":"Jin X, Li YM. Systematic review and meta-analysis from Chinese literature: the association between Helicobacter pylori eradication and improvement of functional dyspepsia. Helicobacter. 2007;12:541\u2013546.","journal-title":"Helicobacter"},{"key":"4871_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002096.pub4","author":"P Moayyedi","year":"2006","unstructured":"Moayyedi P, Soo S, Deeks J, et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev. 2006. https:\/\/doi.org\/10.1002\/14651858.CD002096.pub4 .","journal-title":"Cochrane Database Syst Rev"},{"key":"4871_CR46","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-230X-14-21","volume":"14","author":"Y Du","year":"2014","unstructured":"Du Y, Bai Y, Xie P, et al. Chronic gastritis in China: a national multi-center survey. BMC Gastroenterol. 2014;14:21.","journal-title":"BMC Gastroenterol"},{"key":"4871_CR47","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1001\/jama.295.13.1566","volume":"295","author":"P Moayyedi","year":"2006","unstructured":"Moayyedi P, Talley NJ, Fennerty MB, et al. Can the clinical history distinguish between organic and functional dyspepsia? JAMA. 2006;295:1566\u20131576.","journal-title":"JAMA"},{"key":"4871_CR48","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-230X-2-17","volume":"2","author":"M Salas","year":"2002","unstructured":"Salas M, Ward A, Caro J. Are proton pump inhibitors the first choice for acute treatment of gastric ulcers? A meta analysis of randomized clinical trials. BMC Gastroenterol. 2002;2:17.","journal-title":"BMC Gastroenterol"},{"key":"4871_CR49","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.cgh.2006.09.012","volume":"5","author":"WH Wang","year":"2007","unstructured":"Wang WH, Huang JQ, Zheng GF, et al. Effects of proton-pump inhibitors on functional dyspepsia: a meta-analysis of randomized placebo-controlled trials. Clin Gastroenterol Hepatol. 2007;5:178\u2013185. (quiz 140).","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4871_CR50","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.3748\/wjg.v16.i19.2323","volume":"16","author":"AB Thomson","year":"2010","unstructured":"Thomson AB, Sauve MD, Kassam N, et al. Safety of the long-term use of proton pump inhibitors. World J Gastroenterol. 2010;16:2323\u20132330.","journal-title":"World J Gastroenterol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-017-4871-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-017-4871-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-017-4871-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T22:26:45Z","timestamp":1751063205000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-017-4871-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,1]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["4871"],"URL":"https:\/\/doi.org\/10.1007\/s10620-017-4871-9","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,1]]}}}